International Integrative Aesthetics Board (IIAB)
Bridging Clinical Innovation, Patient Safety, and Holistic Aesthetic Care Worldwide
About the Board
The International Integrative Aesthetics Board (IIAB) is a global advisory body established to bridge the gap between clinical aesthetics, dermatological innovations, and holistic medical practices. Founded with IAMAC as a primary advisory member, IIAB sets cross-border benchmarks for safety, continuous medical education, and evidence-based aesthetic therapies.
Aim & Objectives
Standardize Global Protocols: Establish evidence-based clinical practices and safety guidelines for aesthetic procedures worldwide.
Promote Integrative Care: Combine medical dermatology, non-invasive aesthetics, and wellness science for comprehensive patient outcomes.
Drive Research & Innovation: Encourage clinical trials, case studies, and peer-reviewed research among medical practitioners.
Facilitate International Collaboration: Connect aesthetic doctors, plastic surgeons, and dermatologists across global healthcare networks.
Study & Research Submissions
IIAB invites registered medical practitioners, researchers, and clinical scholars to submit original research papers, clinical trials, and innovative case reports for publication and presentation at international symposia.
Focus Areas: Advanced injectables, regenerative aesthetic medicine, laser safety, and integrative skin health.
Submission Format: Abstracts must follow standard peer-review formats (Introduction, Methodology, Results, Conclusion).
Submission Portal: Submissions can be sent directly to
research@iamac.inwith the subject line “IIAB Research Paper Submission
Membership & Board Opportunities
Joining the IIAB offers medical professionals global recognition, board certification pathways, and opportunities to serve on international advisory panels.
Associate Fellow Member: For newly certified medical aesthetic practitioners seeking mentorship and research access.
Senior Board Fellow: Reserved for experienced practitioners (5+ years) contributing actively to clinical research and board governance.
Advisory Council Seat: By invitation and peer nomination for leading global experts shaping aesthetic medical policy.
